张攀;张宜凡;陈群力;杜望春;姚虹;赵梅;
ZHANG Pan;ZHANG Yi-fan;CHEN Qun-li;DU Wang-chun;YAO Hong;ZHAO Mei;Graduate School, Shanghai University of Chinese Medicine;Department of Pharmacy, Shanghai University of Medicine & Health Sciences;

• 1:上海中医药大学研究生院
• 2:上海健康医学院药学院

摘要(Abstract)：

乳腺肿瘤已成为发病率最高的恶性肿瘤之一,严重威胁人类尤其是女性健康。化疗是抗乳腺肿瘤的重要治疗方法,其通过单独使用或与手术、放射治疗结合使用,几乎可用于乳腺肿瘤治疗的各个阶段。生物碱类化合物是自然界普遍存在的一类天然产物,是多种药用植物的重要活性成分。大量的研究表明,生物碱类化合物可通过抑制增殖、转移和血管生成、抗有丝分裂、促进细胞凋亡和自噬、触发细胞周期阻滞等多种途径发挥抗乳腺肿瘤作用。生物碱类化合物广泛的抗乳腺肿瘤作用使其成为重要的抗乳腺肿瘤候选药物来源。该文就生物碱类天然产物抗乳腺肿瘤机制展开综述。
Breast tumor has become one of the malignant tumors with the highest incidence, and is a serious threat to human health, especially to women. Chemotherapy is an important anti-breast tumor therapy, which can be used in almost every stage of breast tumor therapy alone or in the combination with surgery and radiation therapy. Alkaloids are a kind of ubiquitous natural products, and important active components of various medicinal plants. A large number of studies have shown that alkaloids could exert an anti-breast tumor effect by inhibiting proliferation, metastasis and angiogenesis, resisting mitosis, promoting apoptosis and autophagy, and triggering cell cycle arrest. The extensive anti-breast tumor effect makes alkaloids an important candidate drug source. This paper reviews the anti-breast tumor mechanism of natural products of alkaloids.

关键词(KeyWords)： 生物碱;乳腺肿瘤;抗肿瘤机制
alkaloids;breast tumor;anti-tumor mechanism

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年基金项目(81602729)

作者(Authors): 张攀;张宜凡;陈群力;杜望春;姚虹;赵梅;
ZHANG Pan;ZHANG Yi-fan;CHEN Qun-li;DU Wang-chun;YAO Hong;ZHAO Mei;Graduate School, Shanghai University of Chinese Medicine;Department of Pharmacy, Shanghai University of Medicine & Health Sciences;

DOI: 10.19540/j.cnki.cjcmm.20201015.601

参考文献(References)：

• [1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA-Cancer J Clin,2018,68(6):394.
• [2] CHEN W Q,ZHENG R S,BAADE P D,et al.Cancer statistics in China,2015[J].CA-Cancer J Clin,2016,66(2):115.
• [3] DE LAURENTIIS M,CIANNIELLO D,CAPUTO R,et al.Treatment of triple negative breast cancer (TNBC) current options and future perspectives[J].Cancer Treat Rev,2010,36:S80.
• [4] WAKS A G,WINER E P.Breast cancer treatment:a review[J].J Am Med Assoc,2019,321(3):288.
• [5] MAUGHAN K L,LUTTERBIE M A,HAM P S.Treatment of breast cancer[J].Am Fam Physician,2010,81(11):1339.
• [6] HARBECK N,GNANT M.Breast cancer[J].Lancet,2017,389(10074):1134.
• [7] ZHAO Y Z,ZHANG Y Y,HAN H,et al.Advances in the antitumor activities and mechanisms of action of steroidal saponins[J].Chin J Nat Med,2018,16(10):732.
• [8] GORDALIZA M.Natural products as leads to anticancer drugs[J].Clin Transl Oncol,2007,9(12):767.
• [9] KAMB A,WEE S,LENGAUER C.Why is cancer drug discovery so difficult[J].Nat Rev Drug Discov,2007,6(2):115.
• [10] MONDAL A,GANDHI A,FIMOGNARI C,et al.Alkaloids for cancer prevention and therapy:current progress and future perspectives[J].Eur J Pharmacol,2019,858:172472.
• [11] LIU C,YANG S,WANG K,et al.Alkaloids from traditional Chinese medicine against hepatocellular carcinoma[J].Biomed Pharmacother,2019,120:109543.
• [12] VERNIERI C,PRISCIANDARO M,NICHETTI F,et al.Oral capecitabine-vinorelbine is associated with longer overall survival when compared to single-agent capecitabine in patients with hormone receptor-positive advanced breast cancer[J].Cancers (Basel),2020,12(3):617.
• [13] UNTCH M,JACKISCH C,SCHNEEWEISS A,et al.Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69):a randomised,phase 3 trial[J].Lancet Oncol,2016,17(3):345.
• [14] THEYS D L,ANDOLFI A,GOIETSENOVEN G V,et al.Lycorine,the main phenanthridine Amaryllidaceae alkaloid,exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli:an investigation of structure-activity relationship and mechanistic insight[J].J Med Chem,2009,52(20):6244.
• [15] LI A,VARNEY M L,VALASEK J,et al.Autocrine role of interleukin-8 in induction of endothelial cell proliferation,survival,migration and MMP-2 production and angiogenesis[J].Angiogenesis,2005,8(1):63.
• [16] KIM S,YOU D,JEONG Y,et al.Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells[J].Phytomedicine,2018,50:43.
• [17] YAO M,FAN X,YUAN B,et al.Berberine inhibits NLRP3 inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell[J].BMC Complement Altern Med,2019,19(1):216.
• [18] HUBER M A,AZOITEI N,BAUMANN B,et al.NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression[J].J Clin Invest,2004,114(4):569.
• [19] YANG J,WEINBERG R A.Epithelial-mesenchymal transition:at the crossroads of development and tumor metastasis[J].Dev Cell,2008,14(6):818.
• [20] LI H Y,LIU H,WANG C H,et al.Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1[J].Nat Immunol,2008,9(5):533.
• [21] CHEN Z K,YUAN Y C,WANG Y Z,et al.Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer[J].Breast Cancer Res Treat,2015,152(1):29.
• [22] WEN Y Y,YANG Z Q,SONG M,et al.SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells[J].Can-cer Sci,2010,101(1):73.
• [23] SONG L,LIU D,ZHAO Y,et al.Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-kappaB activation mediated by IL-4/miR-324-5p/CUEDC2 axis[J].Biochem Biophys Res Commun,2015,464(3):705.
• [24] GAO G,LIANG X,MA W.Sinomenine restrains breast cancer cells proliferation,migration and invasion via modulation of miR-29/PDCD-4 axis[J].Artif Cells Nanomed Biotechnol,2019,47(1):3839.
• [25] GE X,LYU P,GU Y,et al.Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells:modulation of PFKFB3 activation[J].Biochem Biophys Res Commun,2015,464(3):862.
• [26] SONG L,LIU D,ZHAO Y,et al.Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHH pathway[J].Biomed Pharmacother,2018,98:687.
• [27] YING X,HUANG A,XING Y,et al.Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway[J].Sci China Life Sci,2017,60(4):417.
• [28] BHATTACHARYA R,KWON J,WANG E,et al.Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF receptor-2 and attenuates endothelial DNA synthesis,but not migration[J].J Mol Signal,2008,3:8.
• [29] WANG J,XU J,XING G.Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway[J].Acta Biochim Biophys Sin,2017,49(9):771.
• [30] NEELAKANTAN D,ZHOU H,OLIPHANT M U J,et al.EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells[J].Nat Commun,2017,8:15773.
• [31] GIALELI C,THEOCHARIS A D,KARAMANOS N K.Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting[J].FEBS J,2011,278(1):16.
• [32] LI M,LI P,ZHANG M,et al.Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions[J].Chin J Integr Med,2018,24(1):40.
• [33] WU G S.Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer[J].Cancer Metastasis Rev,2007,26(3/4):579.
• [34] DU J,WANG X F,ZHOU Q M,et al.Evodiamine induces apoptosis and inhibits metastasis in MDAMB-231 human breast cancer cells in vitro and in vivo[J].Oncol Rep,2013,30(2):685.
• [35] ZHOU X,LEI Q Y.Regulation of TAZ in cancer[J].Protein Cell,2016,7(8):548.
• [36] DING Y,HE J,HUANG J,et al.Harmine induces anticancer activity in breast cancer cells via targeting TAZ[J].Int J Oncol,2019,54(6):1995.
• [37] SETHI N,DAI X,WINTER C G,et al.Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells[J].Cancer Cell,2011,19(2):192.
• [38] SETHI N,KANG Y.Notch signalling in cancer progression and bone metastasis[J].Br J Cancer,2011,105(12):1805.
• [39] HU K F,KONG X Y,ZHONG M C,et al.Brucine inhibits bone metastasis of breast cancer cells by suppressing Jagged1/Notch1 signaling pathways[J].Chin J Integr Med,2017,23(2):110.
• [40] ARENA G,RISCAL R,LINARES L K,et al.MDM2 controls gene expression independently of p53 in both normal and cancer cells[J].Cell Death Differ,2018,25(9):1533.
• [41] OLA M S,NAWAZ M,AHSAN H.Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J].Mol Cell Biochem,2011,351(1/2):41.
• [42] JIN H O,LEE Y H,PARK J A,et al.Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells[J].J Cancer Res Clin Oncol,2014,140(12):2039.
• [43] BARRETT C S,MILLENA A C,KHAN S A.TGF-β effects on prostate cancer cell migration and invasion require FosB[J].HHS Public Access,2017,77(1):72.
• [44] PARK J A,NA H H,JIN H O,et al.Increased expression of FosB through reactive oxygen species accumulation functions as pro-apoptotic protein in piperlongumine treated MCF7 breast can-cer cells[J].Mol Cells,2019,42(12):884.
• [45] SHRIVASTAVA S,KULKARNI P,THUMMURI D,et al.Pi-perlongumine,an alkaloid causes inhibition of PI3K/AKT/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells[J].Apoptosis,2014,19(7):1148.
• [46] SU Q,WANG J,FAN M,et al.Sanguinarine disrupts the colocalization and interaction of HIF-1alpha with tyrosine and serine phosphorylated-STAT3 in breast cancer[J].J Cell Mol Med,2020,24(6):3756.
• [47] CHOI W Y,KIM G Y,LEE W H,et al.Sanguinarine,a benzophenanthridine alkaloid,induces apoptosis in MDA-MB-231 human breast carcinoma cells through a reactive oxygen species-mediated mitochondrial pathway[J].Chemotherapy,2008,54(4):279.
• [48] KALOGRIS C,GARULLI C,PIETRELLA L,et al.Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition[J].Biochem Pharmacol,2014,90(3):226.
• [49] KIM S,LEE T,LEEM J,et al.Sanguinarine-induced apoptosis:generation of ROS,down-regulation of Bcl-2,c-FLIP,and synergy with TRAIL[J].J Cell Biochem,2008,104(3):895.
• [50] XU Z,CHEN X,FU S,et al.Dehydrocorydaline inhibits breast cancer cells proliferation by inducing apoptosis in MCF-7 cells[J].Am J Chin Med,2012,40(1):177.
• [51] ZHAO Y,JING Z,LV J,et al.Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo[J].Biomed Pharmacother,2017,95:18.
• [52] XIE J,XU Y,HUANG X,et al.Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway[J].Tumour Biol,2015,36(2):1279.
• [53] FAYETTE J,SORIA J C,ARMAND J P.Use of angiogenesis inhibitors in tumour treatment[J].Eur J Cancer,2005,41(8):1109.
• [54] WEN Z D,HUANG C H,XU Y Y,et al.α-Solanine inhibits vascular endothelial growth factor expression by down-regulating the ERK1/2-HIF-1α and STAT3 signaling pathways[J].Eur J Pharmacol,2016,771:93.
• [55] MOHSENIKIA M,ALIZADEH A M,KHODAYARI S,et al.The protective and therapeutic effects of alpha-solanine on mice breast cancer[J].Eur J Pharmacol,2013,718(1/3):1.
• [56] ATMACA H,UZUNOGLU S.Anti-angiogenic effects of trabectedin (Yondelis;ET-743) on human breast cancer cells[J].Eur Cytokine Netw,2014,25(1):1.
• [57] SHARMA S,GURU S K,MANDA S,et al.A marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K/AKT/mTOR signaling cascade[J].Chem Biol Interact,2017,275:47.
• [58] CHENG Y,REN X C,HAIT W N,et al.Therapeutic targeting of autophagy in disease:biology and pharmacology[J].Pharmacol Rev,2013,65(4):1162.
• [59] MORETTI L,YANG E S,KIM K W,et al.Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy[J].Drug Resist Updat,2007,10(4/5):135.
• [60] WANG F,MAO Y,YOU Q J,et al.Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway[J].Int J Immunopathol Pharmacol,2015,28(3):362.
• [61] GAO S M,LI X Y,DING X,et al.Cepharanthine induces autophagy,apoptosis and cell cycle arrest in breast cancer cells[J].Cell Physiol Biochem,2017,41(4):1633.
• [62] WANG H Q,LIU T,LI L,et al.Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species[J].Cell Biosci,2015,5:4.
• [63] LU J,SUN D,GAO S,et al.Cyclovirobuxine D induces autophagy-associated cell death via the AKT/mTOR pathway in MCF-7 human breast cancer cells[J].J Pharmacol Sci,2014,125(1):74.
• [64] TIAN W,XIE X J,CAO P L.Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways[J].Biomed Pharmacother,2020,121:109139.
• [65] COLABUFO N A,BERARDI F,CANTORE M,et al.Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases:pharmaceutical,biological,and diagnostic potentials[J].J Med Chem,2010,53(5):1883.
• [66] HE S,LIU F,XIE Z,et al.P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells[J].Int J Mol Sci,2010,11(9):3309.
• [67] ZHOU B G,WEI C S,ZHANG S,et al.Matrine reversed multidrug resistance of breast cancer MCF-7/ADR cells through PI3K/AKT signaling pathway[J].J Cell Biochem,2018,119(5):3885.
• [68] SUMMERS M A,MOORE J L,MCAULEY J W.Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy[J].Ann Pharmacother,2004,38(10):1631.
• [69] TIAN Y,QIAN S,JIANG Y,et al.The interaction between human breast cancer resistance protein (BCRP) and five bisbenzylisoquinoline alkaloids[J].Int J Pharm,2013,453(2):371.
• [70] KADIOGLU O,WONG V K W,LAW B Y K,et al.Mode of action analyses of neferine,a bisbenzylisoquinoline alkaloid of lotus (Nelumbo nucifera) against multidrug-resistant tumor cells[J].Front Pharmacol,2017,8:238.
• [71] LIU Y L,YAN Z X,XIA Y,et al.Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2 STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression[J].Am J Cancer Res,2020,10(3):939.
• [72] ZHANG Y,LIU X,ZUO T,et al.Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein[J].Med Oncol,2012,29(2):534.
• [73] CHEN Y H,QIN Y,LI L,et al.Morphine can inhibit the growth of breast cancer MCF-7 cells by arresting the cell cycle and inducing apoptosis[J].Biol Pharm Bull,2017,40(10):1686.
• [74] THOENNISSEN N H,O′KELLY J,LU D,et al.Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and-negative breast cancer cells by modulating the EGFR/HER-2 pathway[J].Oncogene,2010,29(2):285.
• [75] JIN Z Q,HAO J,YANG X,et al.Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2[J].Oncol Rep,2018,40(4):2127.
• [76] JORDAN M A,WILSON L.Microtubules as a target for anticancer drugs[J].Nat Rev Cancer,2004,4(4):253.
• [77] SUN Y J,LIN X Y,CHANG H.Proliferation inhibition and apoptosis of breast cancer MCF-7 cells under the influence of colchicine[J].J BUON,2016,21(3):570.
• [78] KINGSTON D G I.Tubulin-interactive natural products as anticancer agents[J].J Nat Prod,2009,72(3):507.
• [79] NAAZ F,HAIDER M R,SHAFI S,et al.Anti-tubulin agents of natural origin targeting taxol,vinca,and colchicine binding domains[J].Eur J Med Chem,2019,171:310.
• [80] JORDAN M A,TOSO R J,THROWER D,et al.Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations[J].Proc Natl Acad Sci USA,1993,90(20):9552.
• [81] WEAVER B A.How taxol/paclitaxel kills cancer cells[J].Mol Biol Cell,2014,25(18):2677.
• [82] KANAGASABA R,LIU S,SALAMA S,et al.Ubiquitin-family modifications of topoisomerase Ⅰ in camptothecin-treated human breast cancer cells[J].Biochemistry,2009,48(14):3176.
• [83] TESAURO C,SIMONSEN A K,ANDERSEN M B,et al.Topoisomerase Ⅰ activity and sensitivity to camptothecin in breast can-cer-derived cells:a comparative study[J].BMC Cancer,2019,19(1):1158.
• [84] LEE J H,BERGER J M.Cell cycle-dependent control and roles of DNA topoisomerase Ⅱ[J].Genes (Basel),2019,10(11):859.
• [85] CANALS A,PURCIOLAS M N,AYMAMí J,et al.The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs[J].Acta Crystallogr D Biol Crystallogr,2005,61(Pt 7):1009.
• [86] MOKHTARI R B,HOMAYOUNI T S,BALUCH N,et al.Combination therapy in combating cancer[J].Oncotarget,2017,8(23):38022.
• [87] SERASANAMBATI M,CHILAKAPATI S R,MANIKONDA P K,et al.Anticancer effects of brucine and gemcitabine combination in MCF-7 human breast cancer cells[J].Nat Prod Res,2015,29(5):484.
• [88] YUAN B,YAO M,WANG X,et al.Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo[J].Cancer Cell Int,2018,18:113.
• [89] FU L W,ZHANG Y M,LIANG Y J,et al.The multidrug resis-tance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells[J].Eur J Cancer,2002,38(3):418.
• [90] FU L W,LIANG Y J,DENG L W,et al.Characterization of tetrandrine,a potent inhibitor of P-glycoprotein-mediated multidrug resistance[J].Cancer Chemother Pharmacol,2004,53(4):349.
• [91] KONO M,FUJII T,LIM B,et al.Androgen receptor function and androgen receptor-targeted therapies in breast cancer:a review[J].JAMA Oncol,2017,3(9):1266.
• [92] PRASAD C P,MANCHANDA M,MOHAPATRA P,et al.WNT5A as a therapeutic target in breast cancer[J].Cancer Metastasis Rev,2018,37(4):767.
• [93] DENG Q P,HU H,YU X F,et al.Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant[J].Nat Commun,2019,10(1):5061.
• [94] PENG W X,HUANG J G,YANG L,et al.Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer[J].Mol Cancer,2017,16(1):161.